Author | Alan H. Bryce, MD | OncLive

Author | Alan H. Bryce, MD

Articles

Dr. Bryce on the FDA Approval of Rucaparib in BRCA-Mutant mCRPC

May 20, 2020

Video

Alan H. Bryce, MD, discusses the accelerated approval of rucaparib (Rubraca) for the treatment of adult patients with BRCA mutation (germline and/or somatic)–associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor–directed therapy and a taxane-based chemotherapy.

Dr. Bryce on Ongoing Research Regarding CDK12 Alterations in Prostate Cancer

January 30, 2020

Video

Alan H. Bryce, MD, discusses ongoing research regarding CDK12 alterations in prostate cancer.

Dr. Bryce on Ongoing Research in Prostate Cancer

January 29, 2020

Video

Alan H. Bryce, MD, assistant professor of medicine and medical director of the Genomic Oncology Clinic, Mayo Clinic, discusses ongoing research in prostate cancer.

Dr. Bryce on Next-Generation Radiopharmaceuticals in Prostate Cancer

January 17, 2020

Video

Alan H. Bryce, MD, assistant professor of medicine, Mayo Clinic, discusses the use of next-generation radiopharmaceuticals in prostate cancer.

x